300 related articles for article (PubMed ID: 35485888)
1. Investigation and Optimization of Hydrogel Microneedles for Transdermal Delivery of Caffeine.
Chandran R; Mohd Tohit ER; Stanslas J; Salim N; Tuan Mahmood TM
Tissue Eng Part C Methods; 2022 Oct; 28(10):545-556. PubMed ID: 35485888
[TBL] [Abstract][Full Text] [Related]
2. Enhanced Transdermal Delivery of Acyclovir via Hydrogel Microneedle Arrays.
Al-Badry AS; Al-Mayahy MH; Scurr DJ
J Pharm Sci; 2023 Apr; 112(4):1011-1019. PubMed ID: 36384194
[TBL] [Abstract][Full Text] [Related]
3. Dissolving polymeric microneedle arrays for electrically assisted transdermal drug delivery.
Garland MJ; Caffarel-Salvador E; Migalska K; Woolfson AD; Donnelly RF
J Control Release; 2012 Apr; 159(1):52-9. PubMed ID: 22265694
[TBL] [Abstract][Full Text] [Related]
4. Enzyme-mediated fabrication of nanocomposite hydrogel microneedles for tunable mechanical strength and controllable transdermal efficiency.
Chi Y; Zheng Y; Pan X; Huang Y; Kang Y; Zhong W; Xu K
Acta Biomater; 2024 Jan; 174():127-140. PubMed ID: 38042262
[TBL] [Abstract][Full Text] [Related]
5. Versatility of hydrogel-forming microneedles in in vitro transdermal delivery of tuberculosis drugs.
Anjani QK; Permana AD; Cárcamo-Martínez Á; Domínguez-Robles J; Tekko IA; Larrañeta E; Vora LK; Ramadon D; Donnelly RF
Eur J Pharm Biopharm; 2021 Jan; 158():294-312. PubMed ID: 33309844
[TBL] [Abstract][Full Text] [Related]
6. Potential of hydrogel-forming and dissolving microneedles for use in paediatric populations.
Caffarel-Salvador E; Tuan-Mahmood TM; McElnay JC; McCarthy HO; Mooney K; Woolfson AD; Donnelly RF
Int J Pharm; 2015 Jul; 489(1-2):158-69. PubMed ID: 25940042
[TBL] [Abstract][Full Text] [Related]
7. Hydrogel Microneedles with Programmed Mesophase Transitions for Controlled Drug Delivery.
Dawud H; Edelstein-Pardo N; Mulamukkil K; Amir RJ; Abu Ammar A
ACS Appl Bio Mater; 2024 Mar; 7(3):1682-1693. PubMed ID: 38335540
[TBL] [Abstract][Full Text] [Related]
8. Development and characterization of a dry reservoir-hydrogel-forming microneedles composite for minimally invasive delivery of cefazolin.
Sabri AHB; Anjani QK; Utomo E; Ripolin A; Donnelly RF
Int J Pharm; 2022 Apr; 617():121593. PubMed ID: 35182702
[TBL] [Abstract][Full Text] [Related]
9. Hydrogel swelling as a trigger to release biodegradable polymer microneedles in skin.
Kim M; Jung B; Park JH
Biomaterials; 2012 Jan; 33(2):668-78. PubMed ID: 22000788
[TBL] [Abstract][Full Text] [Related]
10. Microwave-Assisted Preparation of Hydrogel-Forming Microneedle Arrays for Transdermal Drug Delivery Applications.
Larrañeta E; Lutton RE; Brady AJ; Vicente-Pérez EM; Woolfson AD; Thakur RR; Donnelly RF
Macromol Mater Eng; 2015 Jun; 300(6):586-595. PubMed ID: 27346983
[TBL] [Abstract][Full Text] [Related]
11. Hydrogel-forming microneedles enhance transdermal delivery of metformin hydrochloride.
Migdadi EM; Courtenay AJ; Tekko IA; McCrudden MTC; Kearney MC; McAlister E; McCarthy HO; Donnelly RF
J Control Release; 2018 Sep; 285():142-151. PubMed ID: 29990526
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of microneedles-assisted in situ depot forming poloxamer gels for sustained transdermal drug delivery.
Khan S; Minhas MU; Tekko IA; Donnelly RF; Thakur RRS
Drug Deliv Transl Res; 2019 Aug; 9(4):764-782. PubMed ID: 30675693
[TBL] [Abstract][Full Text] [Related]
13. Hydrogel-forming microneedles prepared from "super swelling" polymers combined with lyophilised wafers for transdermal drug delivery.
Donnelly RF; McCrudden MT; Zaid Alkilani A; Larrañeta E; McAlister E; Courtenay AJ; Kearney MC; Singh TR; McCarthy HO; Kett VL; Caffarel-Salvador E; Al-Zahrani S; Woolfson AD
PLoS One; 2014; 9(10):e111547. PubMed ID: 25360806
[TBL] [Abstract][Full Text] [Related]
14. Rapidly dissolving polymeric microneedles for minimally invasive intraocular drug delivery.
Thakur RR; Tekko IA; Al-Shammari F; Ali AA; McCarthy H; Donnelly RF
Drug Deliv Transl Res; 2016 Dec; 6(6):800-815. PubMed ID: 27709355
[TBL] [Abstract][Full Text] [Related]
15. Microneedle-iontophoresis combinations for enhanced transdermal drug delivery.
Donnelly RF; Garland MJ; Alkilani AZ
Methods Mol Biol; 2014; 1141():121-32. PubMed ID: 24567135
[TBL] [Abstract][Full Text] [Related]
16. Development of Hydrogels for Microneedle-Assisted Transdermal Delivery of Naloxone for Opioid-Induced Pruritus.
Gao X; Brogden NK
J Pharm Sci; 2019 Nov; 108(11):3695-3703. PubMed ID: 31476312
[TBL] [Abstract][Full Text] [Related]
17. Novel in situ forming hydrogel microneedles for transdermal drug delivery.
Sivaraman A; Banga AK
Drug Deliv Transl Res; 2017 Feb; 7(1):16-26. PubMed ID: 27562294
[TBL] [Abstract][Full Text] [Related]
18. A new paradigm for numerical simulation of microneedle-based drug delivery aided by histology of microneedle-pierced skin.
Han T; Das DB
J Pharm Sci; 2015 Jun; 104(6):1993-2007. PubMed ID: 25821048
[TBL] [Abstract][Full Text] [Related]
19. Microneedle-Mediated Transdermal Delivery of Bevacizumab.
Courtenay AJ; McCrudden MTC; McAvoy KJ; McCarthy HO; Donnelly RF
Mol Pharm; 2018 Aug; 15(8):3545-3556. PubMed ID: 29996645
[TBL] [Abstract][Full Text] [Related]
20. Laser-engineered dissolving microneedle arrays for transdermal macromolecular drug delivery.
Migalska K; Morrow DI; Garland MJ; Thakur R; Woolfson AD; Donnelly RF
Pharm Res; 2011 Aug; 28(8):1919-30. PubMed ID: 21437789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
